134 related articles for article (PubMed ID: 9096990)
1. Glycemic control and prevention of retinopathy in Japanese NIDDM patients. A 10-year follow-up study.
Nakagami T; Kawahara R; Hori S; Omori Y
Diabetes Care; 1997 Apr; 20(4):621-2. PubMed ID: 9096990
[TBL] [Abstract][Full Text] [Related]
2. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
[TBL] [Abstract][Full Text] [Related]
3. Role of glycemic control and blood pressure in the development and progression of nephropathy in elderly Japanese NIDDM patients.
Tanaka Y; Atsumi Y; Matsuoka K; Onuma T; Tohjima T; Kawamori R
Diabetes Care; 1998 Jan; 21(1):116-20. PubMed ID: 9538981
[TBL] [Abstract][Full Text] [Related]
4. Progression of retinopathy after change of treatment from oral antihyperglycemic agents to insulin in patients with NIDDM.
Henricsson M; Janzon L; Groop L
Diabetes Care; 1995 Dec; 18(12):1571-6. PubMed ID: 8722053
[TBL] [Abstract][Full Text] [Related]
5. The frequency and severity of retinopathy are related to HbA1c values after, but not at, the diagnosis of NIDDM.
Henricsson M; Gottsäter A; Jeppsson JO; Fernlund P; Sundkvist G
J Intern Med; 1998 Aug; 244(2):149-54. PubMed ID: 10095801
[TBL] [Abstract][Full Text] [Related]
6. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
[TBL] [Abstract][Full Text] [Related]
7. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
Ohkubo Y; Kishikawa H; Araki E; Miyata T; Isami S; Motoyoshi S; Kojima Y; Furuyoshi N; Shichiri M
Diabetes Res Clin Pract; 1995 May; 28(2):103-17. PubMed ID: 7587918
[TBL] [Abstract][Full Text] [Related]
8. Incidence and progression of diabetic retinopathy among non-insulin-dependent diabetic subjects: a 4-year follow-up.
Chen MS; Kao CS; Fu CC; Chen CJ; Tai TY
Int J Epidemiol; 1995 Aug; 24(4):787-95. PubMed ID: 8550277
[TBL] [Abstract][Full Text] [Related]
9. Existence of early-onset NIDDM Japanese demonstrating severe diabetic complications.
Yokoyama H; Okudaira M; Otani T; Takaike H; Miura J; Saeki A; Uchigata Y; Omori Y
Diabetes Care; 1997 May; 20(5):844-7. PubMed ID: 9135953
[TBL] [Abstract][Full Text] [Related]
10. Development and progression of diabetic retinopathy in Koreans with NIDDM.
Kim HK; Kim CH; Kim SW; Park JY; Hong SK; Yoon YH; Lee KU
Diabetes Care; 1998 Jan; 21(1):134-8. PubMed ID: 9538984
[TBL] [Abstract][Full Text] [Related]
11. Good blood glucose control characterizes patients without retinopathy after long diabetes duration.
Kullberg CE; Arnqvist HJ
Diabet Med; 1995 Apr; 12(4):314-20. PubMed ID: 7600746
[TBL] [Abstract][Full Text] [Related]
12. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
[TBL] [Abstract][Full Text] [Related]
13. Glycaemic control and development of retinopathy in type 2 diabetes mellitus: a longitudinal study.
Guillausseau PJ; Massin P; Charles MA; Allaguy H; Güvenli Z; Virally M; Tielmans D; Assayag M; Warnet A; Lubetzki J
Diabet Med; 1998 Feb; 15(2):151-5. PubMed ID: 9507917
[TBL] [Abstract][Full Text] [Related]
14. Physician and patient prevention practices in NIDDM in a large urban managed-care organization.
Martin TL; Selby JV; Zhang D
Diabetes Care; 1995 Aug; 18(8):1124-32. PubMed ID: 7587847
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors of diabetic retinopathy in subjects with suboptimal glycemic, blood pressure and lipid control. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, Report 33).
Raman R; Gupta A; Kulothungan V; Sharma T
Curr Eye Res; 2012 Jun; 37(6):513-23. PubMed ID: 22577770
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of retinopathy in patients with type 1 diabetes treated with education-based intensified insulin therapy and its association with parameters of glucose control.
Hatz K; Minder AE; Lehmann R; Drescher T; Gerendas B; Schmidt-Erfurth U; Kaider A; Pruente C; Zulewski H
Diabetes Res Clin Pract; 2019 Feb; 148():234-239. PubMed ID: 30684505
[TBL] [Abstract][Full Text] [Related]
17. High systolic blood pressure increases prevalence and severity of retinopathy in NIDDM patients.
Cignarelli M; De Cicco ML; Damato A; Paternostro A; Pagliarini S; Santoro S; Cardia L; De Pergola G; Giorgino R
Diabetes Care; 1992 Aug; 15(8):1002-8. PubMed ID: 1505300
[TBL] [Abstract][Full Text] [Related]
18. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
19. Data collection on retinopathy as a public health tool: The Hubble telescope equivalent of looking back in time.
Constantino MI; Molyneaux L; Wu T; Twigg SM; Wong J; Yue DK
J Diabetes Complications; 2017 Apr; 31(4):721-725. PubMed ID: 28161385
[TBL] [Abstract][Full Text] [Related]
20. Long-term glycemic control has a nonlinear association to the frequency of background retinopathy in adolescents with diabetes. Follow-up of the Berlin Retinopathy Study.
Danne T; Weber B; Hartmann R; Enders I; Burger W; Hovener G
Diabetes Care; 1994 Dec; 17(12):1390-6. PubMed ID: 7882807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
